Kenney MJ, Ganta CK, Fels RJ. Disinhibition of RVLM neural circuits and regulation of sympathetic nerve discharge at peak hyperthermia. J Appl Physiol 115: 1297-1303, 2013. First published August 29, 2013 doi:10.1152/japplphysiol.00494.2013.-Hyperthermia is a potent activator of visceral sympathetic nerve discharge (SND), and the functional integrity of the rostral ventral lateral medulla (RVLM) is critically important for sustaining sympathoexcitation at peak hyperthermia. However, RVLM mechanisms mediating SND activation to acute heat stress are not well understood. Because RVLM GABA is tonically inhibitory to sympathetic nerve outflow, it is plausible to hypothesize that disinhibition of RVLM sympathetic neural circuits, via withdrawal of GABAergic tone, may affect SND regulation at peak hyperthermia. The effect of RVLM bicuculline (BIC; GABAA receptor antagonist, 100-200 pmol) microinjections on the level of renal SND in anesthetized rats was determined after internal body temperature (Tc) had been increased to 41.5°C. Temperature-control experiments involved RVLM BIC (100 -200 pmol) microinjections, with Tc maintained at 38°C. As expected, acute heating significantly increased renal SND from control levels. Bilateral RVLM BIC microinjections at 41.5°C produced immediate and significant increases in renal SND above heating-induced levels of activation. Bilateral RVLM BIC microinjections at 38°C increased renal SND to similar levels as produced by RVLM BIC microinjections after Tc had been increased to 41.5°C (heating ϩ RVLM BIC). These results demonstrate that a considerable level of RVLM GABAergic inhibition is sustained at peak hyperthermia, an interesting physiological response profile based on the significance of SND activation to cardiovascular regulation during heat stress.
HYPERTHERMIA IS A PHYSIOLOGICAL stressor that produces marked activation of sympathetic nerve outflow. Acute elevations in internal body temperature (Tc) increase muscle sympathetic nerve discharge (SND) in conscious humans (5, 31) , splanchnic SND in conscious rats (24) , and visceral SND (renal, splanchnic, splenic, adrenal) and lumbar SND in anesthetized rats (12, (15) (16) (17) (18) (19) (20) (21) . Sympathetic activation during acute heating plays a critical role in mediating cardiovascular responses to increased Tc (16, 23) . Midbrain-transected rats demonstrate potent visceral sympathoexcitation to acute heating, indicating that intact neural connections between forebrain and brain stem neural circuits are not obligatory for mediating hyperthermiainduced sympathetic activation (21) . On the other hand, cervical spinal cord-transected rats do not demonstrate the full expression of SND responses to acute heating (21) , indicating the importance of supraspinal sympathetic neural circuits in mediating SND responses to acute hyperthermia. Collectively, these findings support an important role for brain stem neural circuits in mediating sympathoexcitatory responses to acute hyperthermia.
The rostral ventral lateral medulla (RVLM) is a brain stem region that plays a critical role in regulation of basal SND (2, 6, 7, 9, 11, 35, 36) . Bilateral inactivation of RVLM neurons produces marked reductions in SND, and RVLM neurons receive tonic excitatory synaptic inputs that activate spinal preganglionic neurons (4, 8, 10, 12, 14, 33, 34) . RVLM neuronal activity is determined by a balance of excitatory and inhibitory inputs, mediated, in large part, to excitatory amino acid and GABA receptors, respectively (2, 7, 9, 11) . RVLM muscimol (GABA A receptor agonist) microinjections decrease SND and mean arterial pressure (MAP) (4, 8, 10, 12, 33, 34) , whereas RVLM microinjections of the excitatory amino acid transmitter, L-glutamate, increase SND and MAP (12, 19, 32) . Blockade of RVLM GABA receptors increases arterial blood pressure and SND (11, 26, 29) , supporting the existence of a tonic inhibitory input to RVLM presympathetic neurons.
Recent studies have investigated the role of the RVLM in mediating SND responses to acute heating in anesthetized rats. Inhibition of RVLM synaptic activity (produced by RVLM muscimol microinjections) markedly reduces hyperthermiainduced visceral sympathetic nerve activation (12) , indicating that the functional integrity of RVLM neural circuits is important for visceral sympathoexcitation at peak hyperthermia. It is well established that RVLM ionotropic excitatory amino acid receptors contribute to cardiovascular and SND responses to a variety of physiological stressors (1, 3, 22, 28, 30) , providing rationale for hypothesizing that antagonism of RVLM ionotropic excitatory amino acid receptors would markedly reduce SND responses at peak hyperthermia. However, Kenney et al. (19) reported that bilateral RVLM microinjections of kynurenic acid (KYN), an ionotropic receptor antagonist, at peak hyperthermia did not reduce and actually tended to or significantly increased levels of visceral SND, suggesting that visceral sympathoexcitation to acute heating is not secondary to activation of RVLM ionotropic glutamate receptors.
Because acute increases in Tc provide a potent stimulus to sympathetic nerve outflow, and the endogenous RVLM GABAergic system is tonically inhibitory to SND (2, 6, 7, 9) , it is plausible to hypothesize that disinhibition of sympathetic neural circuits, via withdrawal of GABAergic tone to RVLM neurons, may markedly alter regulation of sympathetic nerve outflow at peak hyperthermia. In the present study, the effect of bilateral disinhibition of RVLM neural circuits produced by bicuculline (BIC; GABA A receptor antagonist) microinjections on the level of renal SND in anesthetized rats was determined after Tc had been increased to 41.5°C. Temperature-control experiments involved determining renal SND responses to RVLM BIC microinjections with Tc maintained at 38°C.
Vehicle-control experiments were completed by determining renal SND responses to RVLM saline microinjections.
METHODS
The experimental procedures and protocols used were performed in accordance with the American Physiological Society's guiding principles for research involving animals and were approved by the Institutional Animal Care and Use Committee at Kansas State University.
General procedures. Experiments were completed using male Sprague-Dawley rats (300 -350 g). Anesthesia was induced by isoflurane (3-5%) and maintained during surgical procedures using isoflurane (1.5-2.5%), ␣-chloralose (80 mg/kg ip), and urethane (800 mg/kg ip) (12, 19) . A catheter was placed in the femoral vein for the intravenous administration of maintenance doses of ␣-chloralose (35-45 mg·kg Ϫ1 ·h Ϫ1 ). Maintenance doses of urethane (200 mg/kg every 4 h) were administered intraperitoneally. The trachea was cannulated with a polyethylene 240 catheter, and rats were paralyzed with gallamine triethiodide (5-10 mg/kg iv, initial dose; 10 -15 mg·kg Ϫ1 ·h Ϫ1 , maintenance dose) and artificially ventilated (19) . Femoral arterial pressure was monitored using a pressure transducer connected to a blood-pressure analyzer. Heart rate (HR) was derived from the pulsatile arterial pressure output of the blood-pressure analyzer. Tc was measured with a thermistor probe inserted approximately 5-6 cm into the colon and was kept at 38°C during surgical interventions by a temperature-controlled table. The adequacy of anesthesia was indicated by the absence of a cardiovascular response to mechanical stimulation of the tail or hindlimb.
Sympathetic nerve recordings. Renal nerve activity was recorded biphasically with a platinum bipolar electrode after capacity-coupled preamplification (bandpass 30 -3,000 Hz) from the central end of cut renal sympathetic nerves (12, 19) . The left renal nerve was isolated retroperitoneally, and nerve-electrode preparations were covered with silicone gel to prevent exposure to room air. Sympathetic nerve potentials were full-wave rectified and integrated (time constant, 10 ms). Total power in renal SND was quantified as volts·seconds (V·s), and SND recordings were corrected for background noise after administration of the ganglionic blocker (GB), chlorisondamine (5 mg/kg iv) (12, 19) .
RVLM microinjections. Rats were placed in a stereotaxic apparatus, the incisor bar was set at Ϫ11 mm (33) , and the brain stem was exposed. As described by Ito and Sved (14) , target stereotaxic coordinates for the RVLM were 1.6 -2.0 mm rostral to calamus scriptorius, 1.7-2.1 mm lateral from midline, and 2.6 -3.2 mm below the dorsal surface of the brain. RVLM microinjections were completed using multibarrel glass micropipettes (3 barrels; outside tip diameter, 40 -70 m) filled with appropriate drugs, with the pipette angled 20°rostrally (33) . Microinjection volumes were determined with the aid of an operating microscope by measuring the displacement of the fluid meniscus in the micropipette barrel with respect to a horizontal grid. The RVLM was functionally identified by completing glutamate (10 mM, 40 nl) (29) microinjections across a range of coordinates to locate the RVLM site producing the largest increase in MAP.
Experimental protocols. Before initiation of experimental protocols, anesthetized rats were allowed to stabilize for 60 min. At the end of the control period, Tc was increased during heating experiments at an approximate rate of 0.08 -0.09°C/min using a heat lamp. End-tidal CO 2 was measured using a microcapnometer and was maintained near 4.0% during experimental interventions by adjusting the frequency of ventilation (control ventilatory rate, approximately 80 -90 strokes/ min; 41.5°C ventilatory rate, approximately 110 -120 strokes/min). Two microinjection experimental protocols were completed, and microinjectate volume was 100 nl for each microinjection. Experiments associated with each of the individual protocols were completed in separate rats, and microinjection experiments within each protocol were completed in separate rats. First, to determine the effect of disinhibition of RVLM neural circuits on renal SND regulation to hyperthermia, bilateral RVLM microinjections of BIC (200 pmol, n ϭ 6; 100 pmol, n ϭ 4) were administered at a Tc of 41.5°C. Volumecontrol experiments (n ϭ 5) were completed by determining SND responses to bilateral microinjections of saline (100 nl) after Tc had been increased to 41.5°C. In a subset of experiments (n ϭ 5), RVLM glutamate (10 mM, 40 nl) microinjections were completed at a Tc of 41.5°C, 4 -6 min after completion of RVLM BIC microinjections at 41.5°C. Second, temperature-control experiments were completed by determining SND responses to bilateral microinjections of BIC (200 pmol, n ϭ 6; 100 pmol, n ϭ 3) or saline (100 nl, n ϭ 4) at a Tc of 38°C. Renal SND, MAP, and HR were recorded continuously during each experiment. Data from experiments using different doses of RVLM BIC did not differ and were combined for presentation. To assess the effectiveness of RVLM GABA A receptor blockade, the reflex inhibition of renal SND, secondary to phenylephrine-induced (3-5 g/kg iv) increases in MAP, was compared before and after RVLM BIC microinjections (n ϭ 5). At the conclusion of experiments, rats were killed via an overdose of methohexital sodium (Brevital, 150 mg/kg iv).
Data and statistical analysis. Values are means Ϯ SE. Renal SND responses are reported as both percent change from baseline values (control) and in absolute terms (V·s). Control values of renal SND were considered as 100%. Statistical analyses included Student's t-tests and ANOVA techniques with a repeated-measures design, followed by Bonferroni post hoc tests. The overall level of statistical significance was P Ͻ 0.05.
RESULTS
Increases in MAP and renal SND in response to L-glutamate microinjections in left and right RVLM sites from all experiments are summarized in Fig. 1 . Increases in MAP (left RVLM: heating, 27 Ϯ 2 mmHg; nonheating control, 26 Ϯ 2 mmHg; right RVLM: heating, 28 Ϯ 3 mmHg; nonheating control, 23 Ϯ 3 mmHg) and renal SND (left RVLM: heating, 128 Ϯ 31%; nonheating control, 112 Ϯ 20%; right RVLM: heating, 132 Ϯ 25%; nonheating control, 129 Ϯ 30%), produced by RVLM L-glutamate microinjections during the initial RVLM mapping procedures, did not differ among rats that were subsequently included in heating or nonheating-control RVLM BIC microinjection groups. 41.5°C, was characterized by the presence of high-amplitude bursts and was increased from levels recorded at 38°C. After RVLM BIC microinjections at 41.5°C, renal SND demonstrated both high-amplitude bursts and continuous, activated background discharge sequences and was increased from levels recorded during hyperthermia alone. RVLM glutamate produced immediate activation of renal SND to levels above RVLM BIC-induced sympathoexcitation. Figure 3 shows summarized renal SND (Fig. 3A) , MAP ( Fig.  3B ), and HR (Fig. 3C ) data during control (38°C) at peak hyperthermia, after Tc had been increased to 41.5°C, and 3-5 min following bilateral RVLM microinjections of either BIC (n ϭ 10) or saline (n ϭ 5), with Tc maintained at 41.5°C. Renal SND data during heating (41.5°C) and after RVLM BIC microinjections at 41.5°C are reported as percent change from control levels. Renal SND and HR, but not MAP, were increased significantly from control levels in both groups after Tc was elevated to 41.5°C. Each variable was increased significantly from peak hyperthermia levels following RVLM BIC but not RVLM saline microinjections at 41.5°C. RVLM glutamate microinjections, completed 4 -6 min after RVLM BIC microinjections at 41.5°C, increased renal SND an additional 37 Ϯ 5% from peak RVLM BIC-induced levels (n ϭ 5). Reflex reductions in renal SND, secondary to phenylephrine-induced increases in MAP, were attenuated significantly after (MAP increased 37 Ϯ 5 mmHg; renal SND reduced 23 Ϯ 9%) compared with before (MAP increased 41 Ϯ 5 mmHg; renal SND reduced 84 Ϯ 10%) RVLM BIC microinjections (n ϭ 5). In experiments involving multiple interventions that increase the level of SND, expressing nerve activity as successive percent changes can mask the robustness of sympathetic activation due to changes in baseline values, an effect that is tempered by reporting absolute levels of SND. Table 1 shows renal SND reported in absolute terms (V·s) during control (38°C), at peak hyperthermia (41.5°C), and following bilateral RVLM microinjections of either BIC or saline at a Tc of 41.5°C (data from experiments reported in Fig. 3) . Changes in the absolute levels of renal SND demonstrate the prominent renal sympathoexcitation to acute heating and to subsequent RVLM BIC microinjections at 41.5°C.
Although summarized data presented in Fig. 3 indicate that MAP remained unchanged from control levels after increasing Tc from 38°C to 41.5°C, there was considerable interexperiment variability in MAP responses during progressive elevations in Tc. This provided an opportunity to segregate experiments by MAP responsiveness and compare renal SND responses with RVLM BIC microinjections at 41.5°C based on different levels of MAP. Figure 4 shows summarized results from a subset of six RVLM BIC microinjection experiments segregated into two groups based on changes in MAP as Tc was increased from 40.5°C to 41.5°C-decreased MAP (hypotension, n ϭ 3) and increased MAP (hypertension, n ϭ 3). Changes in MAP, renal SND, and HR to increases in Tc from 40.5°C to 41.5°C are shown, as are changes in the same variables, recorded 3-5 min after bilateral RVLM BIC micro- injections at a Tc of 41.5°C. Changes in MAP between groups (hypotension, Ϫ17 Ϯ 2 mmHg; hypertension, 12 Ϯ 1 mmHg) were significantly different after increasing Tc from 40.5°C to 41.5°C. Heating-induced increases in renal SND were significantly attenuated in rats with reduced MAP compared with rats demonstrating increased MAP after elevating Tc from 40.5°C to 41.5°C. RVLM BIC microinjections at 41.5°C increased renal SND, MAP, and HR in both groups, with the BIC-induced change in MAP significantly higher in the hypotension compared with the hypertension group. Figure 5 shows summarized renal SND (Fig. 5A) , MAP (Fig.  5B) , and HR (Fig. 5C ) data recorded at a Tc of 38°C during control and 3-5 min after bilateral RVLM microinjections of either BIC (n ϭ 9) or saline (n ϭ 4). Renal SND, after RVLM BIC microinjections, is reported as percent change from control levels (Fig. 5) . Renal SND, MAP, and HR were increased significantly from control levels following RVLM BIC but not RVLM saline microinjections with Tc maintained at 38°C. Table 2 shows renal SND reported in absolute terms (V·s) during control and after bilateral RVLM microinjections of either BIC or saline from experiments reported in Fig. 5 . Changes in the absolute levels of renal SND demonstrate the marked activation of renal SND to RVLM BIC microinjections at 38°C.
Renal SND responses to RVLM BIC microinjections at 38°C (data from Fig. 5 ) and to acute heat stress that increased Tc to 41.5°C, followed by RVLM BIC microinjections at 41.5°C (data from Fig. 3 ), are shown in Fig. 6 . The total level of renal sympathoexcitation did not differ in rats administered RVLM BIC microinjections at a Tc of 38°C (renal SND, 215 Ϯ 38%) compared with rats that completed an initial period of acute heat stress that increased Tc to 41.5°C, followed by RVLM BIC microinjections at peak hyperthermia (heating to 41.5°C ϩ RVLM BIC at 41.5°C; renal SND, 236 Ϯ 26%).
DISCUSSION
Acute heat stress provides a potent stimulus for activation of visceral sympathetic nerve outflow and substantially affects cardiovascular regulation. In the present study, after increasing Tc to 41.5°C, bilateral disinhibition of RVLM neural circuits produced by BIC microinjections resulted in immediate and marked increases in renal SND above heating-induced sympathoexcitatory responses. The augmentation of heating-induced renal SND activation in response to RVLM BIC microinjection indicates that RVLM GABA provides a substantial level of inhibition to sympathetic neural circuits at peak hyperthermia, a significant finding based on the marked increases in visceral SND produced by increased Tc and the importance of SND activation to cardiovascular regulation during acute heat stress (16, 23) . Regarding this latter point, MAP was increased in parallel with renal SND following RVLM BIC microinjections at 41.5°C.
Although the summarized results demonstrate that RVLM BIC microinjections increase renal SND above peak levels during acute heating, we speculated that a more complete withdrawal of GABAergic inhibition to RVLM neural circuits may be evident in a subgroup of experiments characterized by combined progressive hypotension and plateaued renal sympathoexcitation occurring in parallel with increased Tc (40.5-41.5°C). We considered that an inability of RVLM BIC to enhance renal sympathoexcitation markedly at peak hyperthermia in these experiments would be evident of a physiological SND ceiling effect, at least regarding the RVLM GABAergic component. The present results demonstrate, however, that RVLM BIC microinjections at 41.5°C in experiments characterized by hypotension and plateaued renal sympathoexcitation produced significant increases in renal SND and MAP, demonstrating a persistent and substantial level of sustained GABAergic inhibition to RVLM presympathetic neurons, even under conditions when it would likely be advantageous to activate sympathetic nerve outflow further to help ameliorate the progressive hypotension. This is an interesting physiological response profile, especially considering that heating-induced activation of visceral SND prominently contributes to cardiovascular regulation during acute heat stress. We also considered the possibility that the physiological response profile, characterized by progressive hypertension and marked renal sympathoexcitation, occurring in parallel with increased Tc (40.5-41.5°C), may be indicative of a more pronounced withdrawal of GABAergic inhibition to RVLM neural circuits. However, RVLM BIC microinjections at 41.5°C in these experiments produced marked activation of renal SND, demonstrating a substantial residual level of GABAergic inhibition to RVLM presympathetic neurons. It is interesting to note that animals demonstrating progressive hypotension during increases in Tc from 40.5°C to 41.5°C were also characterized by attenuated levels of renal sympathetic activation, arguing against a baroreceptor-mediated augmentation of SND responses in hypotensive animals. Moreover, renal SND responses to RVLM BIC microinjections at 41.5°C were similar despite variable levels of MAP (hypotension and hypertension)-responses that would be expected to modulate the excitatory input to the caudal ventral lateral medulla from neurons in the nucleus tractus solitarius, thereby influencing the prominent inhibitory GABAergic input to the RVLM arising from the caudal ventral lateral medulla (2, 6, 7, 9) . Thus despite a substantial degree of variability in MAP responses to progressive hyperthermia, the current results suggest that the arterial baroreceptors are not critically involved in altering the GABAergic tone to the RVLM, at least under the specific conditions of these experiments.
We reported previously that antagonism of autonomic ganglionic neural transmission at peak hyperthermia reduced arterial blood pressure to levels below those following GB under basal conditions, suggesting that heating-induced activation of SND is critical for counteracting vasodilatory influences during acute heat stress (16) . In addition, loss of splanchnic vasoconstriction, secondary to denervation of the celiac ganglion, adversely affects cardiovascular regulation during acute heating (23) . An unanswered line of inquiry centers on trying to understand why such a prominent, endogenous GABAergic inhibitory tone to RVLM sympathetic neural circuits persists at peak hyperthermia, especially when cardiovascular alterations are critically involved in the pathophysiological consequences of heat stroke.
Bilateral RVLM BIC microinjections in experiments with Tc maintained at 38°C increased renal SND to levels comparable with those produced by RVLM BIC microinjections after Tc had been increased to 41.5°C (heating ϩ RVLM BIC). Visceral sympathoexcitation to acute heating is not reduced in response to bilateral RVLM KYN microinjections at peak Values are means Ϯ SE.
hyperthermia (19) , ruling out a contributing role for ionotropic excitatory amino acid receptors in hyperthermia-induced SND activation and suggesting that withdrawal of GABAergic tone to RVLM presympathetic neurons, i.e., disinhibition of sympathetic neural circuits, may contribute to heating-induced sympathetic activation. The present study provided an experimental venue for considering this possibility. If endogenous disinhibition of RVLM neural circuits secondary to withdrawal of GABAergic tone to RVLM neurons does not contribute to heating-induced renal sympathoexcitation, it would be expected that peak levels of renal SND in combined heating ϩ RVLM BIC experiments would approximately equal the sum of heating-induced SND activation plus the level of SND activation produced in response to RVLM BIC microinjections at 38°C. However, this was not the case, as levels of renal SND recorded in response to RVLM BIC microinjections at 38°C were similar to levels attained in combined heating ϩ RVLM BIC experiments. RVLM glutamate microinjections completed after combined heating ϩ RVLM BIC produced additional activation of renal SND, suggesting that the level of SND activation after RVLM BIC microinjections did not represent a RVLM activation ceiling. Together, these data suggest that withdrawal of GABAergic tone to RVLM sympathetic neural circuits may contribute to renal SND activation to acute heating. Because of experimental difficulties associated with completing peripheral sympathetic nerve recordings and brain stem microinjections in conscious rats, the present experiments were completed in anesthetized rats, using an anesthetic regimen (urethane-chloralose) that is widely used in experimental studies involving autonomic neurophysiological measurements. Importantly, acute heat stress produces sympathoexcitation in conscious humans (5, 31) , conscious rats (24) , and young, anesthetized rats (12, (15) (16) (17) (18) (19) (20) (21) . The RVLM was successfully targeted in the present study, as demonstrated by the significant increases in arterial blood pressure and renal SND produced in response to bilateral glutamate microinjections at target coordinates. A limitation of central nervous system microinjection studies involves the inability to assess precisely the diffusion area of the microinjectate; therefore, it is difficult to know exactly how much of the RVLM was affected by the BIC microinjections. However, in the current experiments, multibarrel micropipettes were used for the RVLM microinjections; therefore, at the same RVLM sites identified by functional mapping procedures, microinjections of BIC increased SND significantly in both normothermic and hyperthermic rats, demonstrating that BIC microinjections were completed at sites associated with sympathetic premotor neurons. Reflex sympathoinhibitory responses secondary to phenylephrine-induced increases in MAP were attenuated after RVLM BIC microinjections, indicating that the BIC doses used in the present study affected RVLM physiological processes. Data from experiments involving serial RVLM BIC microinjections were not included, because at least in our hands, levels of SND failed to return to baseline values following the initial RVLM BIC microinjections. RVLM saline microinjections elicited no substantial effect on renal SND, indicating that RVLM BICinduced increases in renal SND were not secondary to vehicle or volume effects.
Perspectives and significance. The acute responsivity of the sympathetic nervous system is a prominent regulatory feature of this arm of the autonomic nervous system and is thought to play a key role in maintaining physiological homeostasis in response to episodes of acute physical stress. Hyperthermia is a potent activator of SND, and the functional integrity of the RVLM is required for sustaining a considerable amount of the visceral sympathoexcitation to acute heating, although contributing mechanisms have remained elusive. This is a significant omission, because activation of the sympathetic nervous system contributes to cardiovascular regulation in response to acute heat stress (16, 23) , and sympathetic nervous system dysfunction and cardiovascular regulatory alterations contribute to the pathophysiological consequences of heat stroke (13, 23, 25, 27) . The present results demonstrate that a considerable degree of GABAergic inhibition to RVLM sympathetic neural circuits persists at peak hyperthermia, an interesting regulatory state based on the significance of SND activation to cardiovascular homeostasis at peak hyperthermia. Moreover, disinhibition of RVLM sympathetic neural circuits may be a regulatory strategy engaged to activate visceral sympathetic nerve outflow in response to acute heating. These data address central mechanisms mediating the acute responsivity of sympathetic activation to acute physical stress and support the idea that regulation of RVLM sympathetic neural circuits involves a high level of regulatory complexity.
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